Gossamer Bio (GOSS) EBT: 2022-2025
Historic EBT for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$48.2 million.
- Gossamer Bio's EBT fell 51.00% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$159.6 million, marking a year-over-year increase of 4.31%. This contributed to the annual value of -$55.6 million for FY2024, which is 69.06% up from last year.
- Latest data reveals that Gossamer Bio reported EBT of -$48.2 million as of Q3 2025, which was down 31.61% from -$36.6 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's EBT registered a high of -$31.9 million during Q3 2024, and its lowest value of -$59.0 million during Q3 2022.
- In the last 3 years, Gossamer Bio's EBT had a median value of -$41.9 million in 2024 and averaged -$42.4 million.
- In the last 5 years, Gossamer Bio's EBT surged by 32.23% in 2023 and then plummeted by 51.00% in 2025.
- Quarterly analysis of 4 years shows Gossamer Bio's EBT stood at -$57.2 million in 2022, then grew by 15.85% to -$48.1 million in 2023, then rose by 26.40% to -$35.4 million in 2024, then tumbled by 51.00% to -$48.2 million in 2025.
- Its EBT stands at -$48.2 million for Q3 2025, versus -$36.6 million for Q2 2025 and -$39.3 million for Q1 2025.